Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia
Completed · Phase 4
Conditions studied: Ventricular Tachycardia
In brief
This is a prospective, non-randomized, multi-center clinical case series evaluating the outcomes of the magnetic navigation system in ventricular tachycardia (VT) cases. Subjects will be evaluated acutely and will be followed clinically at 1, 6 and 12 months post-treatment.
Key facts
- Study ID
- NCT00851279
- Run by
- Stereotaxis
- People needed
- 53
- Starts
- 2009-06-01
- Expected to finish
- 2013-04-01
- Last updated by the study team
- 2015-08-24
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject must be between the ages of 18 - 80 years
- Willing to provide prior written informed consent per local ethics committee guidelines
- Subjects must present with ventricular tachycardia, characterized by: history of myocardial scar and spontaneous ventricular tachycardia
- Able to be safely exposed to static magnetic fields
- No in-situ devices are present or any in-situ devices have been verified to be compatible to magnetic fields
You may not qualify if…
- Presence of a mobile ventricular thrombus
- Inability to access the left ventricle
- Subjects must not have any contraindications to short-term anticoagulation
- Subjects must not have a life expectancy of <1 year due to a medical illness
Where it is running
- Krannert Institute of Cardiology — Indianapolis, Indiana, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Na Homolce Hospital — Prague, Czechia
- Herzzentrum Universitat Leipzig — Leipzig, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.